Related Experiment Video
Updated: May 28, 2025

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Rheumatoid meningitis in the absence of active synovitis: A potential association of semaphorin 4A
Keishu Murakami1, Yoshiaki Nakayama1, Shigeru Iwata2
1Department of Neurology, Wakayama Medical University, Wakayama, Japan.
Abstract:
Rheumatoid meningitis (RM) is a rare complication that can develop even in patients with inactive rheumatoid arthritis (RA). Currently, there are no reliable indicators that reflect the disease activity of RM, and its pathogenesis remains poorly understood. Herein, we presented three cases of RM without active synovitis and investigated the possible association between RM and semaphorin 4A (Sema4A). Two of the three patients with RM developed sudden onset of seizures, while one patient exhibited a slowly progressive gait disturbance and cognitive impairment. All the patients had inactive synovitis, positive anti-cyclic citrullinated peptide antibodies in the serum, high-intensity lesions on the cerebral surface on head magnetic resonance imaging, or a favorable response to glucocorticoids. Serum and cerebrospinal fluid (CSF) Sema4A levels in patients with RM were elevated during the acute phase compared to those in the remission phase. Serum Sema4A was significantly increased in patients with RM than in RA controls (23.8 ng/ml versus 7.48 ng/ml, p = 0.014), although there were no significant differences in RA disease activity between the two groups. Sema4A was expressed in a few infiltrating cells and stromal tissues of the RM leptomeninges. This is the first report to demonstrate that serum and CSF Sema4A levels correlate with the disease activity of RM sine active synovitis. The expression of Sema4A in the leptomeninges may be associated with RM pathogenesis.
Insights
Rheumatoid meningitis (RM), a rare complication of rheumatoid arthritis (RA), may be linked to elevated semaphorin 4A (Sema4A) levels. This finding offers a potential biomarker for RM disease activity, even without active synovitis.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Rheumatoid meningitis (RM) is a rare complication of rheumatoid arthritis (RA) that can occur even with inactive disease.
- Current diagnostic indicators for RM disease activity are lacking, and its underlying pathogenesis is poorly understood.
- This study explores the role of semaphorin 4A (Sema4A) in RM, particularly in cases without active synovitis.
Purpose of the Study:
- To investigate the potential association between rheumatoid meningitis (RM) and semaphorin 4A (Sema4A).
- To determine if Sema4A levels correlate with RM disease activity in patients with inactive synovitis.
- To explore the role of Sema4A in the pathogenesis of RM.
Main Methods:
- Case study of three patients with RM presenting with neurological symptoms and inactive synovitis.
- Measurement of serum and cerebrospinal fluid (CSF) Sema4A levels during acute and remission phases.
- Comparison of Sema4A levels in RM patients versus rheumatoid arthritis (RA) controls.
- Immunohistochemical analysis of Sema4A expression in RM leptomeninges.
Main Results:
- Patients with RM exhibited elevated serum and CSF Sema4A levels during the acute phase compared to remission.
- Serum Sema4A levels were significantly higher in RM patients than in RA controls (23.8 ng/ml vs. 7.48 ng/ml, p=0.014).
- Sema4A was detected in infiltrating cells and stromal tissues within the RM leptomeninges.
Conclusions:
- Serum and CSF Sema4A levels correlate with RM disease activity, even in the absence of active synovitis.
- Sema4A may serve as a potential biomarker for monitoring RM activity.
- Sema4A expression in the leptomeninges suggests a role in RM pathogenesis.
More Related Videos
04:49Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
07:15In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
Published on: October 20, 2013